About Affymetrix

Stock Quote

Security
AFFX (Common Stock)
$9.19
+0.33%
Current Day's High
9.37
Current Day's Low
8.95
Current Day's Volume
1,152,284
Last Trade
Sep 03 15 4:00 p.m. ET
Exchange
NASDAQ

The stock price performance shown on the quote above is not necessarily indicative of future price performance

Investors

Investor Relations Contact

Doug Farrell
VP Investor Relations & Treasury
Tel. 408-731-5285
Fax. 408-731-5750
investor@affymetrix.com

Investor Kit

Download Documentation2014 Annual Report
Download Documentation2015 Proxy

Recent News

TitleDate
Affymetrix Reports New Employee Stock Grants
SANTA CLARA, Calif.--(BUSINESS WIRE)--Aug. 21, 2015-- Affymetrix (NASDAQ:AFFX) today announced that equity awards were made to 13 new non-executive officer employees as inducement to join Affymetrix. The equity awards were granted pursuant to NASDAQ Marketplace Rule 5635(c)(4) under the Affymetrix, Inc. 2012 Inducement Plan, which the Board of Directors of Affymetrix adopted for the granting of inducement equity awards to new employees. ... 
08/21/15
Affymetrix Announces 2015 Tumor Profiling Grant Award Recipients to Support Translational Cancer Research
SANTA CLARA, Calif.--(BUSINESS WIRE)--Aug. 11, 2015-- Affymetrix, Inc. (Nasdaq:AFFX) has announced three recipients of the 2015 United States Affymetrix Tumor Profiling Grant Program. The grant program, first launched in 2014, is designed to support translational cancer researchers in the discovery and validation of novel diagnostic, prognostic, and therapeutic biomarkers that may address an unmet clinical need. The qualifying grant projects must ... 
08/11/15
Affymetrix Reports Second Quarter 2015 Operating Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jul. 29, 2015-- Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2015. Results for the three months ended June 30, 2015: Reported revenue growth of 4.1% and 7.9% on a constant currency basis. Total revenue was $89.0 million, compared to $85.4 million in second quarter of 2014. GAAP net income was $7.0 ... 
07/29/15
Cytox and Affymetrix form strategic partnership to develop and commercialize blood-based genetic assay for Alzheimer’s disease risk assessment
20 July 2015: Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). Dr. Richard Pither, CEO ... 
07/20/15
Genotyping Begins on NIDA’s Biorepository of Over 50,000 Samples – Affymetrix, BioRealm, and RUCDR Infinite Biologics Team up to Help Study the Genetics of Addiction
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jul. 7, 2015-- Affymetrix, Inc. (NASDAQ:AFFX), BioRealm, LLC, and RUCDR Infinite Biologics today announced a broad strategic alliance. This alliance will leverage BioRealm's SmokeScreen® platform to genotype the National Institute on Drug Abuse (NIDA) biorepository of more than 50,000 samples, collected from human subjects studied in NIDA-funded research. NIDA preserves these samples in a biorepository ... 
07/07/15
Affymetrix to Report Second Quarter 2015 Operating Results on Wednesday July 29, 2015
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jul. 6, 2015-- Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will report operating results for the second quarter of 2015 after market close on Wednesday July 29, 2015. The company will hold a conference call on the same day at 5:00pm ET. A live webcast can be accessed by visiting the Investor Relations section of the company’s website at www.affymetrix.com. Alternatively, investors and other ... 
07/06/15
Affymetrix Appoints Riccardo Pigliucci to Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--May 18, 2015-- Affymetrix (NASDAQ: AFFX) today announced that Riccardo Pigliucci has been appointed to the company’s board of directors effective May 13, 2015. Mr. Pigliucci will serve as a member of the Compensation Committee. Mr. Pigliucci has served as the Managing Partner of Aldwych Associates, LLP, a management and technology consulting partnership since 2006. Prior to joining Aldwych Associates, ... 
05/18/15
Affymetrix Acquires Assets of Eureka Genomics Corporation to Provide High Throughput and Economical Crop and Animal Genotyping
SANTA CLARA, Calif.--(BUSINESS WIRE)--May 14, 2015-- Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics® Corporation for $15 million in an all cash transaction. Eureka Genomics is a developer of cost-effective, low- to mid-plex, high throughput genotyping assays that use common next-generation sequencing (NGS) platforms for signal readout. These assays enab... 
05/14/15
Affymetrix Reports First Quarter 2015 Operating Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Apr. 29, 2015-- Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the first quarter of 2015. Results for the three months ended March 31, 2015: Reported revenue growth of 6.9% and 9.1% on a constant currency basis. Total revenue was $88.7 million, compared to $83.0 million in first quarter of 2014. Product revenue was $79.4 ... 
04/29/15
Affymetrix and EverGene Ltd., a Subsidiary of MTI Ltd., Collaborate in Genetic Research and Personal Genomics Services in Japan
SANTA CLARA, Calif. & TOKYO--(BUSINESS WIRE)--Apr. 13, 2015-- Affymetrix (NASDAQ:AFFX) and MTI Ltd. (TSE:9438), through its wholly-owned subsidiary, EverGene Ltd., (MTI/EG) announce that the two companies will collaborate in genetic research and personal genomics services in Japan. With the support of leading academics and through this collaboration, MTI/EG plans to further expand their business in the healthcare field. MTI/EG, a perso... 
04/13/15
Affymetrix to Report First Quarter 2015 Operating Results on Wednesday April 29, 2015
SANTA CLARA, Calif.--(BUSINESS WIRE)--Apr. 6, 2015-- Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the first quarter of 2015 after market close on Wednesday April 29, 2015. The company will hold a conference call on the same day at 5:00pm ET. A live webcast can be accessed by visiting the Investor Relations section of the company’s website at www.affymetrix.com. Alternatively, investors and other... 
04/06/15
Affymetrix to Webcast Presentation at the 2015 Leerink Global Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb. 6, 2015-- Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company’s presentation at the Leerink Global Healthcare Conference in New York City on Wednesday February 11, 2015. The live webcast is scheduled to begin at 10:15 a.m. ET and will feature a corporate update by Frank Witney, president and chief executive officer. A live webcast will be available at http://www.affymetrix.com... 
02/06/15
Affymetrix Reports Fourth Quarter and Fiscal Year 2014 Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb. 4, 2015-- Affymetrix, Inc. (NASDAQ:AFFX) today reported its operating results for the three and twelve months ended December 31, 2014. Results for the year ended December 31, 2014: Total revenue was $349.0 million, as compared to total revenue of $330.4 million in 2013. Total revenue grew by 8.9% in 2014, after adjusting for a one-time license payment of $5.3 million in 2013 and ... 
02/04/15
Affymetrix Chairman and Founder to Retire from Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 30, 2015-- Affymetrix (NASDAQ:AFFX) today announced that Founder and Chairman, Stephen Fodor, Ph.D., will retire from the company’s Board of Directors effective January 30, 2015. He has served on the Board since the Company’s inception, and has been Chairman since 1999. The Board of Directors elected Jami Nachtsheim as Chairwoman of the Company’s Board of Directors, succeeding Dr. Fodor. Ms. Nachtsheim ha... 
01/30/15
Affymetrix to Report Fourth Quarter and Fiscal Year 2014 Operating Results on Wednesday February 4, 2015
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 22, 2015-- Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will report operating results for the fourth quarter and fiscal year 2014 after market close on Wednesday February 4, 2015. The company will hold a conference call on the same day at 5:00pm ET. A live webcast can be accessed by visiting the Investor Relations section of the company’s website at www.affymetrix.com. Alternatively, inv... 
01/22/15

Receive Email Alerts

Sign up to receive e-mail alerts whenever Affymetrix posts new information to the site. Just enter your e-mail address and click Submit.


Data provided by Nasdaq. Minimum 15 minutes delayed.

Back to Top >